{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "marketState": "POSTPOST", "regularMarketChangePercent": -2.6284382, "regularMarketPrice": 65.2, "exchange": "SHZ", "shortName": "BETTA PHARMACEUTIC", "longName": "Betta Pharmaceuticals Co., Ltd.", "messageBoardId": "finmb_262922747", "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "cn_market", "esgPopulated": false, "regularMarketTime": 1683875092, "earningsTimestamp": 1628593140, "earningsTimestampStart": 1659956340, "earningsTimestampEnd": 1660305600, "trailingAnnualDividendRate": 0.07, "trailingPE": 241.48146, "trailingAnnualDividendYield": 0.0010454003, "epsTrailingTwelveMonths": 0.27, "epsForward": 1.19, "epsCurrentYear": 0.77, "priceEpsCurrentYear": 84.67532, "sharesOutstanding": 417467008, "bookValue": 11.722, "fiftyDayAverage": 61.4704, "fiftyDayAverageChange": 3.7295952, "fiftyDayAverageChangePercent": 0.060673025, "twoHundredDayAverage": 53.88765, "twoHundredDayAverageChange": 11.312347, "twoHundredDayAverageChangePercent": 0.20992468, "marketCap": 27218847744, "forwardPE": 54.78991, "priceToBook": 5.5621905, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.9 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1478655000000, "priceHint": 2, "regularMarketChange": -1.7600021, "regularMarketDayHigh": 67.23, "regularMarketDayRange": "65.0 - 67.23", "regularMarketDayLow": 65.0, "regularMarketVolume": 3547535, "regularMarketPreviousClose": 66.96, "bid": 65.4, "ask": 65.42, "bidSize": 0, "askSize": 0, "fullExchangeName": "Shenzhen", "financialCurrency": "CNY", "regularMarketOpen": 66.35, "averageDailyVolume3Month": 4084225, "averageDailyVolume10Day": 4693026, "fiftyTwoWeekLowChange": 25.659996, "fiftyTwoWeekLowChangePercent": 0.648963, "fiftyTwoWeekRange": "39.54 - 74.83", "fiftyTwoWeekHighChange": -9.630005, "fiftyTwoWeekHighChangePercent": -0.12869176, "fiftyTwoWeekLow": 39.54, "fiftyTwoWeekHigh": 74.83, "symbol": "300558.SZ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 355, Xingzhong Road", "address2": "Yuhang Eco & Tech Dev Zn", "city": "Hangzhou", "country": "China", "phone": "86 571 8613 0357", "website": "https://www.bettapharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China.", "fullTimeEmployees": 1961, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lieming  Ding", "age": 59, "title": "Founder, Chairman of Directors, CEO & GM", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fan  Jianxun", "age": 50, "title": "VP & Chief Financial Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jiang  Wan", "age": 54, "title": "Sr. VP, Chief Operations Officer & Non Independent Director", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jiabing  Wang", "age": 59, "title": "Sr. VP, Chief Scientific Officer & Non Independent Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lingxi  Wu", "age": 39, "title": "Board Sec. & Head of Chairman Office", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yinxiang  Wang", "age": 57, "title": "Pres", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wanyu  Cai", "age": 60, "title": "Sr. VP", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hao  Wu", "age": 49, "title": "Sr. Director, Head of Hangzhou R&D Center and Supervisor", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wenxin  Xu", "title": "Sr. Director & Head of Immunology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Fuqiang  Liu", "title": "VP & Head of CMC", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 5, "compensationRisk": 2, "shareHolderRightsRisk": 2, "overallRisk": 2, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}